TCON

TRACON Pharmaceuticals, Inc. Common Stock
TCON

Overview Fund Activity
Delisted

TCON was delisted on the 27th of June, 2024.

Back to rankings

44 hedge funds and large institutions have $39M invested in TRACON Pharmaceuticals, Inc. Common Stock in 2021 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 11 increasing their positions, 11 reducing their positions, and 6 closing their positions.

Holders
44
Holders Change
–
Holders Change %
0%
% of All Funds
0.77%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.02%
New
8
Increased
11
Reduced
11
Closed
6
Calls
$439K
Puts
$204K
Net Calls
+$235K
Net Calls Change
+$330K

Top Buyers

1
ACM
1
Altium Capital Management
New York
$3.04M
2
PVH
2
Psagot Value Holdings
Israel
$556K
3
Millennium Management
3
Millennium Management
New York
$540K
4
Renaissance Technologies
4
Renaissance Technologies
New York
$1.19M
5
TI
5
Telemetry Investments
New York
$505K

Top Sellers

1
Deutsche Bank
1
Deutsche Bank
Germany
$1K
2
Marshall Wace
2
Marshall Wace
United Kingdom
$0
3
SFI
3
Susquehanna Fundamental Investments
Pennsylvania
$0
4
Dimensional Fund Advisors
4
Dimensional Fund Advisors
Texas
$87K
5
T. Rowe Price Associates
5
T. Rowe Price Associates
Maryland
$0
Name Market Value Shares Shares
Change 		Shares
Change %
Susquehanna International Group
51
Susquehanna International Group
Pennsylvania
– – – –
Simplex Trading
52
Simplex Trading
Illinois
– – – –
CFGS
53
Concourse Financial Group Securities
Alabama
– – – –
1 2
3